Additive impact of HER2‐/PTK6‐RNAi on interactions with HER3 or IGF‐1R leads to reduced breast cancer progression in vivo

The human epidermal growth factor receptor 2 (HER2) and the protein tyrosine kinase 6 (PTK6) are often co‐ and over‐expressed in invasive breast cancers. At early diagnosis, only distinct groups, such as HER2‐or hormone receptor‐positive benefit from a targeted therapy. However, a part of these tumo...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Mol Oncol
Hoofdauteurs: Falkenberg, Natalie, Anastasov, Nataša, Höfig, Ines, Bashkueva, Ksenia, Lindner, Katrin, Höfler, Heinz, Rosemann, Michael, Aubele, Michaela
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2014
Onderwerpen:
Research Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528674/
https://ncbi.nlm.nih.gov/pubmed/25241146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.08.012
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items